| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 06/07/2001 | WO2001040211A1 A PROCESS FOR THE PREPARATION OF {2-[4-(α-PHENYL-p-CHLOROBENZYL)PIPERAZIN-1-YL]ETHOXY}ACETIC ACID AND NOVEL INTERMEDIATES THEREFOR |
| 06/07/2001 | WO2001040188A1 Curcumin analogues for treating cancer |
| 06/07/2001 | WO2001040147A1 Catalysis using phosphine oxide compounds |
| 06/07/2001 | WO2001039769A1 Hypoglycemics comprising organic zinc (ii) complexes |
| 06/07/2001 | WO2001030749B1 Novel compounds |
| 06/07/2001 | US20010003121 Adamantane derivatives such as 2,4-dichloro-N-(tricyclo(3.3.1.13,7)dec-1-methyl)-benzamide; administering to treat rheumatoid arthritis; immunosuppressant |
| 06/07/2001 | DE19958496A1 Verfahren zur Herstellung von 5-(1-Piperazinyl)-benzofuran-2-carboxamid durch Übergangsmetallkatalysierte Aminierung A process for the preparation of 5- (1-piperazinyl) benzofuran-2-carboxamide by transition metal amination |
| 06/07/2001 | CA2393440A1 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 06/06/2001 | EP1104413A2 Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them |
| 06/06/2001 | EP0873329B1 Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands |
| 06/06/2001 | CN1298399A Substituted alxoxycarbonyl compounds |
| 06/06/2001 | CN1298299A Antibacterial agents |
| 06/05/2001 | US6242644 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 06/05/2001 | US6242606 Reacting a a,a-dimethylphenylacetic acid amide with a w-halo compound produces w'-halo-a-keto-a,a-dimethylphenylacetic acid amide and reacting it with a piperidine compound; 2-(4-(4-chloro-butyryl)-phenyl)-2-methy-propionic acid |
| 06/05/2001 | US6242605 Aryloxy-alkyl-dialkylamines |
| 06/05/2001 | US6242596 Preparation of betamethyl carbapenem intermediates |
| 06/05/2001 | US6242495 Compounds and compositions for delivering active agents |
| 06/05/2001 | US6242494 Angiogenesis inhibitors, antitumor agents, diabetic retinopathy, and antiinflammatory agents |
| 06/05/2001 | US6242470 Rheumatic diseases; antiarthritic agents, antiallergens; irritable bowel syndrome; amidation |
| 06/05/2001 | CA2039073C Method of removing water from a dilute solution of n-methylmorpholine-n-oxide, n-methylmorpholine, or morpholine |
| 05/31/2001 | WO2001038561A1 Methods of use of peptide deformylase inhibitors as novel antibacterial agents |
| 05/31/2001 | WO2001038309A1 β-AMINO ACID-, ASPARTIC ACID- AND DIAMINOPROPIONIC-BASED INHIBITORS OF FACTOR Xa |
| 05/31/2001 | WO2001037826A1 Npyy5 antagonists |
| 05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors |
| 05/31/2001 | DE19957672A1 Purification and drying of crude pyrrolidine, used as intermediate e.g. in synthesis of plant protection agents and pharmaceuticals, involves continuous distillation in distillation and concentration column at reduced pressure |
| 05/31/2001 | CA2392576A1 .beta.-amino acid-, aspartic acid- and diaminopropionic-based inhibitors of factor xa |
| 05/30/2001 | EP1103552A1 Benzothiepin derivatives, process for the preparation of the same and uses thereof |
| 05/30/2001 | EP1103536A1 Process for the preparation of chiral amines by asymmetric hydrogenation of enamines |
| 05/30/2001 | EP1102743A1 Amide derivatives which are useful as cytokine inhibitors |
| 05/30/2001 | EP1102739A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors |
| 05/30/2001 | EP1102538A1 Plant growth regulator compositions |
| 05/30/2001 | CN1297441A Heterocyclically substd. amides used as calpain inhibitors |
| 05/30/2001 | CN1066444C Nitrogenous derivs. for elemene and their use as anticancer drugs |
| 05/30/2001 | CN1066438C Preparation of beta-methyl carbapenem intermediates |
| 05/29/2001 | US6239313 From an inclusion complex of epoxide with cyclodextrin and nucleophilic compound |
| 05/29/2001 | US6239277 Alkylation of amine group in piperazine ring |
| 05/29/2001 | US6239179 N-aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands |
| 05/29/2001 | US6239175 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
| 05/29/2001 | US6239154 Arylacetamides, agonists at kappa opioid receptors. |
| 05/29/2001 | US6239151 Compounds as inhibitor of tumor necrosis factor alpha release |
| 05/29/2001 | US6239135 Arylpiperazines having activity at the serotonin 1A receptor |
| 05/25/2001 | WO2001036403A1 Urea derivatives as anti-inflammatory agents |
| 05/25/2001 | WO2001036386A1 Diabetic remedy containing dipiperazine derivative |
| 05/25/2001 | WO2001036376A1 Novel phenylalanine derivatives |
| 05/25/2001 | WO2001036375A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders |
| 05/25/2001 | WO2001036374A2 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments |
| 05/25/2001 | WO2001036360A1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 05/25/2001 | WO2000077027A3 Serine protease inhibitors |
| 05/25/2001 | WO2000039081A3 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/24/2001 | US20010001799 Anticoagulant |
| 05/23/2001 | EP1101755A1 Anthranilic acid derivatives |
| 05/23/2001 | EP1100794A1 COMPOUNDS SPECIFIC FOR THE HUMAN $g(a) 1d? ADRENERGIC RECEPTOR AND USES THEREOF |
| 05/23/2001 | EP1100790A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
| 05/23/2001 | EP1100763A1 Diketoacid-derivatives as inhibitors of polymerases |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/23/2001 | EP1100503A2 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 05/23/2001 | EP1100495A1 Propenamides as ccr5 modulators |
| 05/23/2001 | EP1100485A1 Substituted anilide compounds and methods |
| 05/23/2001 | EP1100483A2 Glucocorticoid-selective anti-inflammatory agents |
| 05/23/2001 | EP0689536B1 Naphthalene derivatives |
| 05/23/2001 | DE19955476A1 Bis-basische Verbindungen als Tryptase-Inhibitoren, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Bis-basic compounds as tryptase inhibitors, to processes for their preparation and their use as medicaments |
| 05/23/2001 | CN1296478A Histamine H3 receptor ligands |
| 05/23/2001 | CN1296477A Piperazine derivatives and process for the preparation thereof |
| 05/23/2001 | CN1296411A Remedies for cardiac dilastolit disorders |
| 05/23/2001 | CN1296382A Plant growth regulator compositions |
| 05/22/2001 | US6235938 Transition metal-catalyzed process for preparing N-aryl amine compounds |
| 05/22/2001 | US6235929 Tripeptide α-ketoamides |
| 05/22/2001 | US6235927 Process for the separation of a mixture of enantiomers |
| 05/22/2001 | US6235875 Human and animal anthelmintic |
| 05/22/2001 | US6235791 Using cis n-cyclohexyl-n-ethyl(3-(3-chloro-cyclohexylphenyl)allyl)amine |
| 05/22/2001 | US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis |
| 05/22/2001 | US6235778 Anticoagulants |
| 05/22/2001 | US6235736 3-anilino-2-cycloalkenone derivatives |
| 05/22/2001 | US6235732 Neurokinin antagonists |
| 05/22/2001 | US6235218 Reacting heterocyclic amine with monoaldehyde or dialdehyde and hydrogen cyanide or alkali metal cyanide in aqueous medium, quaternizing amine with alkylating agent at ph controlled to prevent formation of protonated intermediate |
| 05/17/2001 | WO2001034591A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/17/2001 | WO2001034588A1 Process for producing benzylamine compound |
| 05/17/2001 | WO2001034587A2 Process for preparing n-(4-hydroxy-phenyl)-n'-(4'-aminophenyl)-piperazine |
| 05/17/2001 | WO2001034586A2 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity |
| 05/17/2001 | WO2001034578A1 Compounds with anti-helicobacter pylori activity |
| 05/17/2001 | WO2001034569A1 Pancreatitis remedies |
| 05/17/2001 | WO2001034561A1 Processes for the preparation of sumatriptan and related compounds |
| 05/17/2001 | WO2001034135A2 Oncolytic combinations for the treatment of cancer |
| 05/17/2001 | CA2390789A1 Oncolytic combinations for the treatment of cancer |
| 05/17/2001 | CA2390524A1 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity |
| 05/17/2001 | CA2389514A1 Processes for the preparation of sumatriptan and related compounds |
| 05/16/2001 | EP1099692A1 N,n-substituted cyclic amine derivatives |
| 05/16/2001 | EP1098892A1 Biphenyl derivatives |
| 05/16/2001 | EP1098870A2 Nitric esters and nitrate salts of specific drugs |
| 05/16/2001 | EP1098864A1 Method for hydrogenating unsaturated heterocyclic compounds |
| 05/16/2001 | EP1098651A2 Novel urokinase inhibitors |
| 05/16/2001 | EP1098642A1 Methods for treating conditions modulated by lactosylceramide |
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
| 05/16/2001 | CN1295475A Medicine for improving optic disc circulation |
| 05/15/2001 | US6232476 Intermediates in a process for cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl}pyrrolidine |
| 05/15/2001 | US6232467 Biosynthesis of an amine with ketone and boron compound; compoundlibraries |
| 05/15/2001 | US6232342 Protease inhibitors |
| 05/15/2001 | US6232336 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 05/15/2001 | US6232314 Arylalkylpiperazine compounds as antioxidants |